3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hepatic differentiation from human mesenchymal stem cells on a novel nanofiber scaffold

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The emerging fields of tissue engineering and biomaterials have begun to provide potential treatment options for liver failure. The goal of the present study is to investigate the ability of a poly L-lactic acid (PLLA) nanofiber scaffold to support and enhance hepatic differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs). A scaffold composed of poly L-lactic acid and collagen was fabricated by the electrospinning technique. After characterizing isolated hMSCs, they were seeded onto PLLA nanofiber scaffolds and induced to differentiate into a hepatocyte lineage. The mRNA levels and protein expression of several important hepatic genes were determined using RT-PCR, immunocytochemistry and ELISA. Flow cytometry revealed that the isolated bone marrow-derived stem cells were positive for hMSC-specific markers CD73, CD44, CD105 and CD166 and negative for hematopoietic markers CD34 and CD45. The differentiation of these stem cells into adipocytes and osteoblasts demonstrated their multipotency. Scanning electron microscopy showed adherence of cells in the nanofiber scaffold during differentiation towards hepatocytes. Our results showed that expression levels of liver-specific markers such as albumin, α-fetoprotein, and cytokeratins 8 and 18 were higher in differentiated cells on the nanofibers than when cultured on plates. Importantly, liver functioning serum proteins, albumin and α-1 antitrypsin were secreted into the culture medium at higher levels by the differentiated cells on the nanofibers than on the plates, demonstrating that our nanofibrous scaffolds promoted and enhanced hepatic differentiation under our culture conditions. Our results show that the engineered PLLA nanofibrous scaffold is a conducive matrix for the differentiation of MSCs into functional hepatocyte-like cells. This represents the first step for the use of this nanofibrous scaffold for culture and differentiation of stem cells that may be employed for tissue engineering and cell-based therapy applications.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Electrospinning: applications in drug delivery and tissue engineering.

          Despite its long history and some preliminary work in tissue engineering nearly 30 years ago, electrospinning has not gained widespread interest as a potential polymer processing technique for applications in tissue engineering and drug delivery until the last 5-10 years. This renewed interest can be attributed to electrospinning's relative ease of use, adaptability, and the ability to fabricate fibers with diameters on the nanometer size scale. Furthermore, the electrospinning process affords the opportunity to engineer scaffolds with micro to nanoscale topography and high porosity similar to the natural extracellular matrix (ECM). The inherently high surface to volume ratio of electrospun scaffolds can enhance cell attachment, drug loading, and mass transfer properties. Various materials can be electrospun including: biodegradable, non-degradable, and natural materials. Electrospun fibers can be oriented or arranged randomly, giving control over both the bulk mechanical properties and the biological response to the scaffold. Drugs ranging from antibiotics and anticancer agents to proteins, DNA, and RNA can be incorporated into electrospun scaffolds. Suspensions containing living cells have even been electrospun successfully. The applications of electrospinning in tissue engineering and drug delivery are nearly limitless. This review summarizes the most recent and state of the art work in electrospinning and its uses in tissue engineering and drug delivery.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Electrospun nanofibrous structure: A novel scaffold for tissue engineering

            The architecture of an engineered tissue substitute plays an important role in modulating tissue growth. A novel poly(D,L-lactide-co-glycolide) (PLGA) structure with a unique architecture produced by an electrospinning process has been developed for tissue-engineering applications. Electrospinning is a process whereby ultra-fine fibers are formed in a high-voltage electrostatic field. The electrospun structure, composed of PLGA fibers ranging from 500 to 800 nm in diameter, features a morphologic similarity to the extracellular matrix (ECM) of natural tissue, which is characterized by a wide range of pore diameter distribution, high porosity, and effective mechanical properties. Such a structure meets the essential design criteria of an ideal engineered scaffold. The favorable cell-matrix interaction within the cellular construct supports the active biocompatibility of the structure. The electrospun nanofibrous structure is capable of supporting cell attachment and proliferation. Cells seeded on this structure tend to maintain phenotypic shape and guided growth according to nanofiber orientation. This novel biodegradable scaffold has potential applications for tissue engineering based upon its unique architecture, which acts to support and guide cell growth. Copyright 2002 Wiley Periodicals, Inc. J Biomed Mater Res 60: 613-621, 2002
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Organ printing: tissue spheroids as building blocks.

              Organ printing can be defined as layer-by-layer additive robotic biofabrication of three-dimensional functional living macrotissues and organ constructs using tissue spheroids as building blocks. The microtissues and tissue spheroids are living materials with certain measurable, evolving and potentially controllable composition, material and biological properties. Closely placed tissue spheroids undergo tissue fusion - a process that represents a fundamental biological and biophysical principle of developmental biology-inspired directed tissue self-assembly. It is possible to engineer small segments of an intraorgan branched vascular tree by using solid and lumenized vascular tissue spheroids. Organ printing could dramatically enhance and transform the field of tissue engineering by enabling large-scale industrial robotic biofabrication of living human organ constructs with "built-in" perfusable intraorgan branched vascular tree. Thus, organ printing is a new emerging enabling technology paradigm which represents a developmental biology-inspired alternative to classic biodegradable solid scaffold-based approaches in tissue engineering.
                Bookmark

                Author and article information

                Contributors
                (916) 734 7901 , (916) 734 8097 , yduan@ucdavis.edu
                +9821 4458 0376 , +9821 4458 0395 , lotfi-ab@nigeb.ac.ir
                Journal
                Cell Mol Biol Lett
                Cell. Mol. Biol. Lett
                Cellular & Molecular Biology Letters
                SP Versita (Heidelberg )
                1425-8153
                1689-1392
                28 December 2011
                March 2012
                : 17
                : 1
                : 89-106
                Affiliations
                [1 ]GRID grid.412266.5, ISNI 0000000117813962, Department of Clinical Biochemistry, Faculty of Medical Science, , Tarbiat Modares University, ; Tehran, I.R. Iran
                [2 ]GRID grid.413079.8, ISNI 0000000097528549, Transplant Research Program, Department of Internal Medicine, , University of California Davis Medical Center, Sacramento, ; 4635 2nd Ave, Suite 1001, California, CA 95817 USA
                [3 ]GRID grid.419420.a, ISNI 0000000086767464, National Institute for Genetic Engineering and Biotechnology, ; Pajuhesh Blvd, Tehran, I.R. Iran
                [4 ]GRID grid.412266.5, ISNI 0000000117813962, Department of Hematology, Faculty of Medical Science, , Tarbiat Modares University, ; Tehran, I.R. Iran
                [5 ]Department of Stem Cells and Tissue Engineering, Stem Cell Technology Co. Ltd., Tehran, I.R. Iran
                Article
                40
                10.2478/s11658-011-0040-x
                6275739
                22207333
                4492e85b-9799-4bdb-a442-203849b4c9e7
                © © Versita Warsaw and Springer-Verlag Wien 2011
                History
                : 29 March 2011
                : 15 December 2011
                Categories
                Research Article
                Custom metadata
                © © Versita Warsaw and Springer-Verlag Wien 2012

                poly l-lactic acid,nanofiber,hepatic differentiation,mesenchymal stem cells,electrospinning

                Comments

                Comment on this article